(Q51933837)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15667381%20AND%20SRC:MED&resulttype=core&format=json

7 January 2020

title

Alteration of a clinically meaningful outcome in the natural history of Alzheimer's disease by cholinesterase inhibition (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15667381%20AND%20SRC:MED&resulttype=core&format=json

7 January 2020

1 reference

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15667381%20AND%20SRC:MED&resulttype=core&format=json

7 January 2020

William E. Klunk

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15667381%20AND%20SRC:MED&resulttype=core&format=json

7 January 2020

Steven T. DeKosky

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15667381%20AND%20SRC:MED&resulttype=core&format=json

7 January 2020

author name string

Oscar L Lopez

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15667381%20AND%20SRC:MED&resulttype=core&format=json

7 January 2020

Judith Saxton

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15667381%20AND%20SRC:MED&resulttype=core&format=json

7 January 2020

Robert A Sweet

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15667381%20AND%20SRC:MED&resulttype=core&format=json

7 January 2020

language of work or name

English

0 references

publication date

1 January 2005

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15667381%20AND%20SRC:MED&resulttype=core&format=json

Journal of the American Geriatrics Society

7 January 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15667381%20AND%20SRC:MED&resulttype=core&format=json

7 January 2020

volume

53

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15667381%20AND%20SRC:MED&resulttype=core&format=json

7 January 2020

issue

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15667381%20AND%20SRC:MED&resulttype=core&format=json

7 January 2020

page(s)

83-87

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15667381%20AND%20SRC:MED&resulttype=core&format=json

A 5-month, randomized, placebo-controlled trial of galantamine in AD. The Galantamine USA-10 Study Group.

7 January 2020

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1532-5415.2005.53015.X

Galantamine in AD: A 6-month randomized, placebo-controlled trial with a 6-month extension. The Galantamine USA-1 Study Group.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1532-5415.2005.53015.X

A 1-year, randomized, placebo-controlled study of donepezil in patients with mild to moderate AD.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1532-5415.2005.53015.X

Long-term tacrine (Cognex) treatment: effects on nursing home placement and mortality, Tacrine Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1532-5415.2005.53015.X

Research evaluation and diagnosis of probable Alzheimer's disease over the last two decades: I.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1532-5415.2005.53015.X

The decline in synapses and cholinergic activity is asynchronous in Alzheimer's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1532-5415.2005.53015.X

A 1-year, placebo-controlled preservation of function survival study of donepezil in AD patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1532-5415.2005.53015.X

10.1111/J.1532-5415.2005.53015.X

21 January 2018

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15667381%20AND%20SRC:MED&resulttype=core&format=json

7 January 2020

1 reference